Beijing Huansheng Medical Investment Co. Ltd. (“Huansheng Medical”) recently announced that it has obtained 100 million of RMB investment on its series A financing. Goldman Sachs, the world’s leading investment bank, invested in this round of financing (“this Investment”).

Huansheng Medical was founded in 2014, which focuses on the development and operation of professional chain kidney and blood purification center. It’s brand “Jing Dialysis Center” is committed to become a leader in independent hemodialysis medical industry in China

The legal services provided by Cathay Associates Kejie for Huansheng Medical on this Investment included, among others, (i) assisting in conducting legal due diligence investigation; (ii) drafting, reviewing and revising transaction documents; (iii) participating in transaction negotiations;(iv) drafting legal opinions.

Cathay Associates Kejie team is led by partner Fred Hao and mainly includes Liu Xiayi and He Yuting.